Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project

Clinical trial NCT06821880 · RECRUITING

Trial details

NCT number: NCT06821880
Sponsor: Medical University Innsbruck
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukaemia (CLL)Multiple Myeloma (MM)Secondary Immunodeficiency (SID)

Start date: 2025-02-03
Primary completion: 2026-07-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.